Press Releases :: BiomX, Inc. (PHGE)

Jun 08, 2023 5:00pm EDT

NYSE American Initiates Delisting Proceedings for BiomX Warrants

May 31, 2023 3:00am EDT

BiomX to Present Part 1 Data from Phase 1b/2a Study Evaluating BX004 for the Treatment of Chronic Pseudomonas aeruginosa Pulmonary Infections in Patients with Cystic Fibrosis During Late-Breaking Science Session at the 46th European Cystic Fibrosis Conference (ECFC)

May 15, 2023 6:30am EDT

BiomX Reports First Quarter 2023 Financial Results and Provides Business Update

May 12, 2023 8:00am EDT

BiomX Announces the Appointments of Jason M. Marks and Michael E. Dambach to Board of Directors

May 08, 2023 6:30am EDT

BiomX to Host First Quarter 2023 Financial Results Conference Call and Webcast on May 15th, 2023

May 05, 2023 6:30am EDT

BiomX Announces Second Closing of $7.5 Million Private Placement

Mar 29, 2023 6:30am EDT

BiomX Reports Fourth Quarter and Full Year 2022 Financial Results and Provides Business Update

Mar 27, 2023 7:00am EDT

BiomX to Host Fourth Quarter and Full Year 2022 Financial Results Conference Call and Webcast on March 29th, 2023

Feb 22, 2023 6:35am EST

BiomX Announces Positive Results from Part 1 of the Phase 1b/2a Study Evaluating BX004 for Treatment of Chronic Pulmonary Infections in Patients with Cystic Fibrosis

Feb 22, 2023 6:30am EST

BiomX Announces $7.5 Million Private Placement

Previous
1
2
3
4
5
6
7
8
9
10
Next

Investor Contact Information

Company

BiomX, Inc.
22 Einstein St.
Floor 5
Ness Ziona 7414003
Israel
info@biomx.com

Investor Relations

Anat Primovich
Corporate Project Manager
T: +972506977228
anatp@biomx.com